Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zhiyun Peng, Guangcheng Wang, Qiao-Hui Zeng, Yufeng Li, Haiquan Liu, Jing Jing Wang & Yong Zhao. (2022) A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship. Critical Reviews in Food Science and Nutrition 62:15, pages 4053-4094.
Read now
Read now
Samaneh Zolghadri, Asieh Bahrami, Mahmud Tareq Hassan Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas & Ali Akbar Saboury. (2019) A comprehensive review on tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 279-309.
Read now
Read now
Articles from other publishers (21)
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, Samineh Massah & Ahmad Reza Massah. (2023) Recent Advances in Biological Active Sulfonamide based Hybrid
Compounds Part C: Multicomponent Sulfonamide Hybrids. Current Medicinal Chemistry 30:37, pages 4181-4255.
Crossref
Crossref
Yuanyuan Wang, Baichen Xiong, Shuaishuai Xing, Ying Chen, Qinghong Liao, Jun Mo, Yao Chen, Qi Li & Haopeng Sun. (2023) Medicinal Prospects of Targeting Tyrosinase: A Feature Review. Current Medicinal Chemistry 30:23, pages 2638-2671.
Crossref
Crossref
Samaneh Zolghadri, Mohammad Beygi, Tasneem F. Mohammad, Mahdi Alijanianzadeh, Thanigaimalai Pillaiyar, Pablo Garcia-Molina, Francisco Garcia-Canovas, Jose Munoz-Munoz & Ali Akbar Saboury. (2023) Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises. Biochemical Pharmacology 212, pages 115574.
Crossref
Crossref
Manpreet Kaur, Rajbir Kaur, Hitakshi Saini & Palwinder Singh. (2023) Design, synthesis and evaluation of vascular endothelial growth factor receptor inhibitors for the potential treatment of human cancers. Journal of Molecular Structure 1276, pages 134819.
Crossref
Crossref
Mateusz Kciuk, Somdutt Mujwar, Beata Marciniak, Adrianna Gielecińska, Karol Bukowski, Mariusz Mojzych & Renata Kontek. (2023) Genotoxicity of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro. International Journal of Molecular Sciences 24:4, pages 4053.
Crossref
Crossref
Sajid Irshad, Saeed Ahmad, Shafi Ullah Khan, Mohsin Abbas Khan, Syeda Abida Ejaz, Huma Rao, Umair Khurshid, Aftab Ahmed, Nadeem Shahzad, Hamad M. Al-kahtani, Affan Waheed, Tanveer A. Wani & Abdullahi Tunde Aborode. (2022)
Synthesis, biochemical characterization and
in silico
investigation of 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid derivatives: dual action mode inhibitors of urease and virulent bacterial stains
. Biochemical Journal 479:19, pages 2035-2048.
Crossref
Crossref
Sajid Irshad, Saeed Ahmad, Mohsin Abbas Khan, Mubashir Aziz, Syeda Abida Ejaz & Muawya Elhadi. (2022) 2‐Chloro‐5‐(1‐hydroxy‐3‐oxoisoindolin‐1‐yl)benzenesulfonamides as potential inhibitors of urease: Synthesis, in‐vitro and molecular modeling approach. Journal of the Chinese Chemical Society.
Crossref
Crossref
Yahya S. Alqahtani, Bandar A. Alyami, Ali O. Alqarni, Mater H. Mahnashi, Anser Ali, Qamar Javed, Mubashir Hassan & Muhammad Ehsan. (2022) Cephalosporin as Potent Urease and Tyrosinase Inhibitor: Exploration through Enzyme Inhibition, Kinetic Mechanism, and Molecular Docking Studies. BioMed Research International 2022, pages 1-11.
Crossref
Crossref
Karol Bukowski, Beata Marciniak, Mateusz Kciuk, Mariusz Mojzych & Renata Kontek. (2022) Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro. Molecules 27:12, pages 3761.
Crossref
Crossref
Adem Korkmaz & Ercan Bursal. (2022) Synthesis, Biological Activity and Molecular Docking Studies of Novel Sulfonate Derivatives Bearing Salicylaldehyde. Chemistry & Biodiversity 19:6.
Crossref
Crossref
Mateusz Kciuk, Somdutt Mujwar, Anna Szymanowska, Beata Marciniak, Karol Bukowski, Mariusz Mojzych & Renata Kontek. (2022) Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies. International Journal of Molecular Sciences 23:11, pages 5892.
Crossref
Crossref
S.M. Ivanov. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV
29
180
.
Seyedeh Roya Alizadeh & Mohammad Ali Ebrahimzadeh. (2021) Pyrazolotriazines: Biological activities, synthetic strategies and recent developments. European Journal of Medicinal Chemistry 223, pages 113537.
Crossref
Crossref
Zofia Bernat, Anna Mieszkowska, Zofia Mazerska, Joanna Matysiak, Zbigniew Karczmarzyk, Katarzyna Kotwica-Mojzych & Mariusz Mojzych. (2021) Chiral Pyrazolo[4,3-e][1,2,4]triazine Sulfonamides—Their Biological Activity, Lipophilicity, Protein Affinity, and Metabolic Transformations. Applied Sciences 11:6, pages 2660.
Crossref
Crossref
Ramil F. Fatykhov, Oleg N. Chupakhin, Vladimir L. Rusinov & Igor A. Khalymbadzha. 2021. Copper in N-Heterocyclic Chemistry. Copper in N-Heterocyclic Chemistry
161
220
.
Asad Hamad, Mohsin Abbas Khan, Khondaker Miraz Rahman, Irshad Ahmad, Zaheer Ul-Haq, Samra Khan & Zahid Shafiq. (2020) Development of sulfonamide-based Schiff bases targeting urease inhibition: Synthesis, characterization, inhibitory activity assessment, molecular docking and ADME studies. Bioorganic Chemistry 102, pages 104057.
Crossref
Crossref
Agnieszka Gornowicz, Anna Szymanowska, Mariusz Mojzych, Krzysztof Bielawski & Anna Bielawska. (2020) The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells. International Journal of Molecular Sciences 21:15, pages 5221.
Crossref
Crossref
Chita R. Sahoo, Sudhir K. Paidesetty & Rabindra N. Padhy. (2019) Nornostocine congeners as potential anticancer drugs: An overview. Drug Development Research 80:7, pages 878-892.
Crossref
Crossref
Muhammad Hanif, Fariha Kanwal, Muhammad Rafiq, Mubashir Hassan, Muhammad Mustaqeem, Sung-Yum Seo, Yunlong Zhang, Changrui Lu, Ting Chen & Muhammad Saleem. (2019) Symmetrical Heterocyclic Cage Skeleton: Synthesis, Urease Inhibition Activity, Kinetic Mechanistic Insight, and Molecular Docking Analyses. Molecules 24:2, pages 312.
Crossref
Crossref
Qi Li, Hongyu Yang, Jun Mo, Yao Chen, Yue Wu, Chen Kang, Yuan Sun & Haopeng Sun. (2018) Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors. PeerJ 6, pages e4206.
Crossref
Crossref
Pervaiz Channar, Aamer Saeed, Fernando Albericio, Fayaz Larik, Qamar Abbas, Mubashir Hassan, Hussain Raza & Sung-Yum Seo. (2017) Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking. Molecules 22:8, pages 1352.
Crossref
Crossref